Genetic Disorders
- 1 January 2022
- book chapter
- Published by Springer Nature
- p. 207-221
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- Clopidogrel: A Case for Indication-Specific PharmacogeneticsClinical Pharmacology & Therapeutics, 2012
- Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysisBritish Journal of General Practice, 2011
- Pharmacogenomic testing: Relevance in medical practiceCleveland Clinic Journal of Medicine, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin DosePLOS Genetics, 2009
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance doseBlood, 2008
- CYP4F2 genetic variant alters required warfarin doseBlood, 2008
- Medical genetics diagnostic evaluation of the child with global developmental delay or intellectual disabilityCurrent Opinion in Neurology, 2008
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004